GIHICHEM API Intermediates

4-Pyridinecarboxamide is a pyridine derivative containing an amide functional group. Amide functional groups are a very important type of functional groups in organic compounds. Many natural compounds, pharmaceutical intermediates and high value-added fine chemicals contain amide functional groups.

Synonym6-[({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)methyl]nicotinic acid; 6-(BOC-AMINOMETHYL)NICOTINIC ACID; 3-Pyridinecarboxylic acid, 6-[[[(1, 1-dimethylethoxy)carbonyl]amino]methyl]-

4-Iodoimidazole, a light yellow solid, is generally used as pharmaceutical intermediates and other fine chemical products. It is in many natural compounds, such as enzymes, nucleic acids, and alkaloids, which play an important role in biological processes.

SynonymCyclopentanecarboxylic acid, 1-(4-cyanophenoxy)-; 1-(4-Cyanophenoxy)cyclopentane-1-carboxylic acid

Synonym2-methyl-1-(methylthio)-2-Propanamine; 2-METHYL-1-(METHYLSULFANYL)PROPAN-2-AMINE; 2-Methyl-1-(methylsulfanyl)-2-propanaChemicalbookmine; 2-methyl-1-methylthio-2-propylamine; 2-Methyl-1-(methylt...

LCZ696 Intermediate, CAS No.1426129-50-1 is a useful intermediate for the preparation of sabibil (S080900) and valsartan (V095750). LCZ696 intermediates are intermediates for organic synthesis and pharmaceutical R&D. They are mainly used as organic intermediates and pharmaceutical intermediates. They can be used in laboratory R&D processes and chemical and pharmaceutical synthesis processes, and can be used in the synthesis of bulk drug LCZ696.

ND-630 is a small molecule and an oral allosteric acetyl CoA carboxylase (ACC) inhibitor, acquired from Nimbus Therapeutics (formerly Nimbus Discovery), being developed by Gilead Sciences for the treatment of non-alcoholic steatohepatitis (NASH) and related fatty liver diseases. (R)-4-(2-bromo-1-(2-methoxyphenyl)ethoxy)tetrahydro-2H-pyra,CAS No.2098543-62-3, is one of the intermediate of ND-630.